NVAXbenzinga

Novavax Announces Prelim. Results From SHIELD-Utah Study Showing Co.'s Vaccine, Adjuvanted (2024-2025 Formula) Resulted In Fewer And Less Severe Reactogenicity Symptoms vs Pfizer-BioNTech mRNA 2024-2025 Vaccine

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 15, 2025 by benzinga